For example, RhoA expression is increased in aging vessels, and klotho deficiency and high salt intake trigger noncanonical Wnt-Rho activation; klotho replacement therapy, Wnt inhibitors, and Rho-kinase inhibitors are expected to be new therapies in aging-associated hypertension [13]. The gene discussed is KL; the disease is hypertensive disorder.